Pooled mutant KRAS-targeted long peptide vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pooled mutant KRAS-targeted long peptide vaccine, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer [Phase 1]